EXFFERIDE® POWDER

EXFFERIDE® POWDER
Product Description

(1) Chronic iron overload due to blood transfusions
(2) Once daily; in fasting state

(3) Easier administration of powder formulation compared to the original’s dispersible tablet 


(4) Wider range of dosage strength
 
(5) KR-1695970 (Expiration date: 2035.07.31)

Read more Show less

Kuhnil Pharm

  • KR
  • 2023
    On CPHI since
  • 250 - 499
    Employees
Company types
Academic/Research
CMO/CDMO
Distributor/Import Export
Generics/Biosimilars Manufacturer
Pharmaceutical company
Primary activities
Pharmaceutical Company (innovator finished products)
View company profile
Categories
more categories Show less
Specifications
  • Details
    - Deferasirox 125, 250, 500, 1000 mg

More specifications Fewer specifications

Kuhnil Pharm

  • KR
  • 2023
    On CPHI since
  • 250 - 499
    Employees
Company types
Academic/Research
CMO/CDMO
Distributor/Import Export
Generics/Biosimilars Manufacturer
Pharmaceutical company
Primary activities
Pharmaceutical Company (innovator finished products)
View company profile

More Products from Kuhnil Pharm (2)

  • ROSUMEGA®

    Product ROSUMEGA®

    (1) Mixed Hyperlipidemia

    (2) Once daily, 2~4 soft capsules per day

    (3) Dual Effect to reduce LCL-C and TG Level by patented technology* (3-layer coating)

    (4) Combo’s additional decrease effect in residual cardiovascular risk & Omega-3’s multiple effects 
    (Lower...
  • OMACOR® MINI CAPSULES

    Product OMACOR® MINI CAPSULES

    (1) Hypertriglyceridemia; Hyperlipidemia

    (2) Once daily, 2g or up to 4g if necessary

    (3) Ideal package for administration of ESC recommended strength of Omega-3          (ESC: European Society of Cardiology)

    (4) Easy to swallow, patient-friendly dosage form

Kuhnil Pharm resources (1)